Director, Portfolio & Product Strategy, NS
Novartis
17 days ago
Remote friendly (East Hanover, NJ)
United States
Marketing
Key Responsibilities:
- Partner with the TA Head, GMs, and ED to build forward-looking competitive readiness plans (strategy, tactical, scenario planning) based on the external competitive environment and internal product/portfolio strategies.
- Support input on assets to S&G, Development, and BioMedical Research to maximize commercial viability and launch value generation, including Life Cycle Management (LCM) planning and Integrated Evidence Plans/LCM Plans for early pipeline assets.
- Partner with US BD&L and US Market Access to provide country-level input for BD&L evaluations (e.g., TPP development, stakeholder research, DC/IMB prep) aligned to C&BD deal archetype guidance.
- Support strategic evaluations/initiatives informing DA and TA strategies, including TAL input such as white/position papers, competitive levers, portfolio mix gaps, and emerging unmet needs.
- Support or lead transition of late-stage pipeline assets from S&G to US Commercial 6+ months before FDP; contribute to FDP submission package and represent US Commercial needs at key forums (up to transition to full IPST).
Education:
- Bachelor’s Degree required; MBA or advanced degree preferred.
Experience (Required):
- Minimum 8 years commercial experience with multiple functional roles (sales, marketing, strategy, market access or medical preferred).
- Recent US market commercialization experience across launches and product lifecycle stages, or General Manager experience in other countries.
- Experience partnering with Medical Affairs and/or Development to inform strategic choices.
- Autonomy, creative problem-solving, portfolio mindset, and leadership/proactive competitive readiness.
Desirable:
- Experience in multiple therapeutic areas.
- Market Access experience a plus.
- Ability to influence leaders 1–2 levels above; thrive in complex, ambiguous environments with tight timelines.
- Partner with the TA Head, GMs, and ED to build forward-looking competitive readiness plans (strategy, tactical, scenario planning) based on the external competitive environment and internal product/portfolio strategies.
- Support input on assets to S&G, Development, and BioMedical Research to maximize commercial viability and launch value generation, including Life Cycle Management (LCM) planning and Integrated Evidence Plans/LCM Plans for early pipeline assets.
- Partner with US BD&L and US Market Access to provide country-level input for BD&L evaluations (e.g., TPP development, stakeholder research, DC/IMB prep) aligned to C&BD deal archetype guidance.
- Support strategic evaluations/initiatives informing DA and TA strategies, including TAL input such as white/position papers, competitive levers, portfolio mix gaps, and emerging unmet needs.
- Support or lead transition of late-stage pipeline assets from S&G to US Commercial 6+ months before FDP; contribute to FDP submission package and represent US Commercial needs at key forums (up to transition to full IPST).
Education:
- Bachelor’s Degree required; MBA or advanced degree preferred.
Experience (Required):
- Minimum 8 years commercial experience with multiple functional roles (sales, marketing, strategy, market access or medical preferred).
- Recent US market commercialization experience across launches and product lifecycle stages, or General Manager experience in other countries.
- Experience partnering with Medical Affairs and/or Development to inform strategic choices.
- Autonomy, creative problem-solving, portfolio mindset, and leadership/proactive competitive readiness.
Desirable:
- Experience in multiple therapeutic areas.
- Market Access experience a plus.
- Ability to influence leaders 1–2 levels above; thrive in complex, ambiguous environments with tight timelines.